Posts

ulrich medical USA®Announces Landmark Achievement 100,000 VBR Implant Milestone

/in /by

Solidifies Spine Market Leadership Position in Vertebral Body Replacement Devices   

ST. LOUIS, MO (June 12, 2019) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, announced today that the company enterprise will surpass the 100,000 implant milestone in 2019 in total vertebral body replacement (VBR) device implantations.

Read more

ulrich medical USA®Announces Strong Continued Growth of U.S. Spine Business

/in /by

Delivers 13 Consecutive Years of Organic Growth and Double Digit Positive EDITDA

ST. LOUIS, MO (April 16, 2019) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported 2018 financial results which continue the company’s achievement of significant year-over-year organic growth for thirteen consecutive years (since 2006).

Read more

ulrich medical USA® Delivers Seventh Consecutive Year of Profitable Double-Digit Growth

/in /by

Reports 15%, 5-Year Revenue CAGR Performance in U.S. Spine Market

ST. LOUIS, MO (March 7, 2018) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported 2017 financial results with 10% annual revenue growth for the year ending December 31, 2017 and a 15%, 5-year compound annual growth rate (CAGR) in their U.S. spine market business.

Read more

ulrich medical USA® Triples U.S. Spine Business

/in /by

Delivers Solid Growth, Revenue Diversification, and Continued Profitability

ST. LOUIS, MO (April 18, 2017) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported full year 2016 financial results with a 15% top line revenue increase for the year ending December 31, 2016 and a 20% growth in EBITDA for the same period.

Read more

ulrich medical USA® Announces Strong Financial Performance of U.S. Spine Business

/in /by

Delivers Record-Breaking 5-Year Results ~ 18% Revenue CAGR and 27% EBITDA CAGR

ST. LOUIS, MO (February 17, 2016) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported a fifth consecutive year of profitable, double-digit growth for the U.S. spine business and a 20% top line growth for the year ending December 31, 2015. Equally as strong, the company announced a 5-year revenue compound annual growth rate (CAGR) of 18% and a 27% EBITDA CAGR over the same period.

Read more

ulrich medical USA® Settles Lawsuit against Amedica®

/in /by

Amedica Agrees to $75,000 Settlement Payment

ST. LOUIS, MO (December 7, 2015) – ulrich medical USA, Inc. (ulrich) today announced it has reached a settlement with Amedica Corporation (Nasdaq: AMDA) in association with a lawsuit that ulrich filed against Amedica alleging a variety of infractions related to the hiring by Amedica of a former ulrich sales director that ulrich alleged violated the former sales director’s Employment Agreement with ulrich, including its confidentiality and noncompetition provisions.

Read more

ulrich medical USA® Announces North American Corporate Expansion

/in /by

Twenty Percent Growth Year-to-Date Caps Four Years of Exceptional U.S. Performance

ST. LOUIS, MO (August 24, 2015) – ulrich medical USA Inc., today announced plans to significantly increase its U.S. workforce in order to accommodate for the increasing demands of its dynamic spine implant business. Fueled by four consecutive years of profitable, double-digit growth and twenty percent year-to-date growth, the company is investing in its future and expanding across multiple functional areas within North America.

Read more

ulrich medical USA® Delivers Four Consecutive Years of Double-Digit Growth

/in /by

ST. LOUIS, MO (March 2, 2015) – ulrich medical USA Inc., today announced a strong financial performance for the year ending December 31, 2014. The company recorded a 15 percent annual growth rate in 2014, which caps off four consecutive years of profitable, double-digit growth for the company.

Read more

ulrich medical USA® Reports Record Results for Third Consecutive Year

/in /by

Expands Current Product Portfolio to Create New Hospital Devices Business Unit

ST. LOUIS, MO (February 26, 2014) – ulrich medical USA, Inc., today announced record revenue growth for the year ending December 31, 2013. The company recorded a 22 percent growth rate in 2013, in addition to its previously reported 13 percent revenue growth in 2012 and 20 percent growth in 2011.

Read more

ulrich medical USA® Honored with Best of Chesterfield Award

/in /by

101-Year-Old Spinal Implant Company Recognized for Long-Term Value to Chesterfield, Missouri

ST. LOUIS, MO (December 16, 2013) – ulrich medical USA, Inc., has been selected for the 2013 Best of Chesterfield Award in the Medical Device Company category by the Chesterfield Award Program.

Read more